| Form type | Sec Links | Description | Filing date | Reporting date |
|---|
Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 10-K | Report | Data | 10-K | Feb 13, 2025 | Dec 31, 2024 |
| 8-K | Report | Data | 8-K | Feb 13, 2025 | Feb 13, 2025 |
| 8-K | Report | Data | 8-K | Jan 13, 2025 | Jan 12, 2025 |
| SC 13G/A | Report | Nov 12, 2024 | ||
| SC 13G/A | Report | SEC SCHEDULE 13G | Nov 8, 2024 | |
| 10-Q | Report | Data | 10-Q | Oct 31, 2024 | Sep 30, 2024 |
| 8-K | Report | Data | 8-K | Oct 31, 2024 | Oct 31, 2024 |
| SC 13G/A | Report | Aug 12, 2024 | ||
| 10-Q | Report | Data | 10-Q | Aug 1, 2024 | Jun 30, 2024 |
| 8-K | Report | Data | 8-K | Aug 1, 2024 | Aug 1, 2024 |
| SC 13G/A | Report | Jul 5, 2024 | ||
| 8-K | Report | Data | 8-K | May 20, 2024 | May 16, 2024 |
| 10-Q | Report | Data | 10-Q | May 2, 2024 | Mar 31, 2024 |
| 8-K | Report | Data | 8-K | May 2, 2024 | May 2, 2024 |
| 8-K | Report | Data | 8-K | Mar 4, 2024 | Mar 4, 2024 |
| 10-K | Report | Data | 10-K | Feb 15, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | ALNYLAM PHARMACEUTICALS, INC. 8-K | Feb 15, 2024 | Feb 15, 2024 |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 13, 2024 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 9, 2024 | |
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 9, 2024 | |
| SC 13G/A | Report | Feb 9, 2024 | ||
| SC 13G/A | Report | Jan 29, 2024 | ||
| SC 13G/A | Report | Jan 26, 2024 | ||
| 8-K | Report | Data | 8-K | Jan 19, 2024 | Jan 12, 2024 |
| 8-K | Report | Data | FORM 8-K | Jan 8, 2024 | Jan 7, 2024 |
| 10-Q | Report | Data | 10-Q | Nov 2, 2023 | Sep 30, 2023 |
| 8-K | Report | Data | ALNYLAM PHARMACEUTICALS, INC. 8-K | Nov 2, 2023 | Nov 2, 2023 |
| 8-K | Report | Data | 8-K | Oct 10, 2023 | Oct 9, 2023 |
| 8-K | Report | Data | 8-K | Sep 28, 2023 | Sep 26, 2023 |
| 10-Q | Report | Data | 10-Q | Aug 3, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | 8-K | Aug 3, 2023 | Jul 31, 2023 |
| 8-K | Report | Data | 8-K | Jul 26, 2023 | Jul 21, 2023 |
| 8-K | Report | Data | 8-K | Jun 30, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | 8-K | May 23, 2023 | May 18, 2023 |
| 10-Q | Report | Data | 10-Q | May 4, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | ALNYLAM PHARMACEUTICALS, INC. 8-K | May 4, 2023 | May 4, 2023 |
| 8-K | Report | Data | 8-K | Mar 8, 2023 | Mar 7, 2023 |
| 10-K | Report | Data | 10-K | Feb 23, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | ALNYLAM PHARMACEUTICALS, INC. 8-K | Feb 23, 2023 | Feb 23, 2023 |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 13, 2023 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 9, 2023 | |
| SC 13G/A | Report | Feb 9, 2023 | ||
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 6, 2023 | |
| SC 13G/A | Report | Jan 31, 2023 | ||
| SC 13G/A | Report | Jan 19, 2023 | ||
| 8-K | Report | Data | FORM 8-K | Jan 9, 2023 | Jan 8, 2023 |
| 8-K | Report | Data | 8-K | Jan 6, 2023 | Jan 5, 2023 |
| 10-Q | Report | Data | 10-Q | Oct 27, 2022 | Sep 30, 2022 |
| 8-K | Report | Data | ALNYLAM PHARMACEUTICALS, INC. 8-K | Oct 27, 2022 | Oct 27, 2022 |